Latest Articlesddd
The biotechnology industry is proving to be the most innovative and the most growing among Wall …
– The second approval of a cancer drug for Exelixis – The approval of Exelixis/Roche drugs …
A Letter From Prohost The Stock Market Selloff What’s Going On and What Do We Do …
but first: Here is some good news from SAREPTA Yesterday we wrote about BioMarin (BMRN) being …
Kite Pharma (Kite) stock was sliding, raising concern about the firm and all the biotech firms …
INOVIO Inovio Pharmaceuticals (INO) is much worth looking at now than 6 months ago. The deal …
In The NEWS IMMUNOTHERAPY MIRATI THERAPEUTICS Mirati Therapeutics (MRTX) is an oncology company focusing on genetic …
The moment the new IPO NantKwest (NK) landed in the town of publicly traded firms, some …
Prohost Letter #381 QUARTERLY FINANCIAL RESULTS IN THE BIOTECH SECTOR Investors Concerns, Excitement and Expectations (Part …
Prohost Letter #380 Investors Concerns, Excitments and Expectations PART 2 REGENERON On Friday, July 24, Regeneron …
Why the financing through a secondary public offering was a must for Exelixis. The outcome of …
The European Commission Approves Amgen’s New Cholesterol-Lowering Medication Repatha™ (evolocumab). The First PCSK9 Inhibitor to Be …
An Effective Non-Steroid Atopic Dermatitis Ointment Anacor Pharmaceuticals (ANAC) Announces Positive Top-Line Results From Two Phase …
Prohost Letter #379 Investors Concerns, Excitments and Expectations It is understandable the fact that bullish and …
After decades of attempting, but failing, to harness the immune system power to treat cancer (Cancer …
Today it is Greece. What About Tomorrow? Can Greece’s crisis devastate the biotech sector? No sane …
On Thursday June 18, 2015, we posted an article under “Today’s Highlights” at the Prohost website …
Prohost Letter #378 Part 2 2015 ASCO ANNUAL MEETING What a Big Revolution in Oncology! The …
– Immunogen’s recurrent ovarian cancer drug Mirvetuximab soravtansine (IMGN853) has demonstrated promising results. – The firm …
VASCULAR BIOGENICS OPERATING AS VBL THERAPEUTICS Vascular Biogenics Ltd., operating as VBL Therapeutics (VBLT) is a …
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Accept Privacy policy
